Kerry R. Hicks's most recent trade in TriSalus Life Sciences Inc was a trade of 56,403 Director Stock Option (right to buy) done . Disclosure was reported to the exchange on May 14, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TriSalus Life Sciences Inc | Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 56,403 | 145,625 | - | - | Director Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2026 | 28,201 | 542,790 | - | 0 | Common Stock | |
| TriSalus Life Sciences Inc | Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 15,000 | 89,222 | - | - | Director Stock Option (right to buy) | |
| TriSalus Life Sciences Inc | Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 15,000 | 15,000 | - | - | Director stock option (right to buy) | |
| TriSalus Life Sciences Inc | Kerry R. Hicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) |